A Simple Thought to Ponder
Happiness is taking pleasure in what you do have.
Tasquinimod – An Anti-Angiogenesis Drug That Delays Prostate Cancer Progression
Johns Hopkins, Roswell Park Cancer Institute and Duke University have announced data at the ASCO meeting in Chicago from a 200 man phase II clinical trial of a blood vessel-blocking drug called tasquinimod. This “anti-angiogenesis” [...]
But, I’m Not Dying!
I received a telephone call recently from a man who was angry and upset. All he could say was, but I’m not dying, I’m not dying! I was finally able to calm him down enough [...]
More From ASCO – Is there A Role for Metformin in Treating Prostate Cancer?
Obesity has been associated with a worse prostate cancer prognosis and increased levels of insulin are thought to mediate this effect. It has been established that hyperinsulinemia associates with higher levels of insulin receptors (IR) [...]
On The Horizon – A Status Report of Six New Promising Advancing Treatments for Men with Advanced Prostate Cancer as of the Beginning of June, 2010
As of today there are many different potential drugs undergoing phase III evaluations for men with advanced prostate cancer, some of them seem to offer great hope and promise. Considering we just had Provenge finally [...]
Denosumab Demonstrates More Efficacy Than Zometa in Prostate Cancer Patients with Bone Metastases
A phase III study released at the ASCO meeting demonstrated that for men with bone metastases from prostate cancer, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as [...]